CIK 0000010795
- Large accelerated filer
BECTON DICKINSON & CO
Sign in to watch- Ticker
- BDX
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Sep 30
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 220760120
- Phone
- +1 201-847-6800
- Business address
- ONE BECTON DR, FRANKLIN LAKES, NJ, 07417-1880
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $688,650
- in 4 filings, $689K under 10b5-1 plans
Net −$688,650. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-26 | Neal Shana Carol EVP and Chief People Officer | Grant or award · Stock Appreciation Rights | +8,264 | 8,264 | ||
| 2024-11-26 | Quinn Michelle EVP and General Counsel | Grant or award | +1,932 | 6,887 | ||
| 2024-11-26 | Quinn Michelle EVP and General Counsel | Grant or award | +416 | 7,303 | ||
| 2024-11-26 | Quinn Michelle EVP and General Counsel | Shares withheld for taxes | −376 | 6,927 | ||
| 2024-11-26 | Quinn Michelle EVP and General Counsel | Grant or award · Stock Appreciation Rights | +7,568 | 7,568 | ||
| 2024-11-26 | Quinn Michelle EVP and General Counsel | Grant or award · Rights to Common Stock Under Deferred Compensation Plan | +416 | 7,984 | ||
| 2024-11-26 | Polen Thomas E Jr Chairman, CEO and President | Grant or award | +15,539 | 87,350 | ||
| 2024-11-26 | Polen Thomas E Jr Chairman, CEO and President | Grant or award | +36,585 | 123,935 | ||
| 2024-11-26 | Polen Thomas E Jr Chairman, CEO and President | Shares withheld for taxes | −23,564 | 100,371 | ||
| 2024-11-26 | Polen Thomas E Jr Chairman, CEO and President | Grant or award · Stock Appreciation Rights | +60,891 | 60,891 | ||
| 2024-11-26 | Byrd Richard EVP & President Interventional | Grant or award | +2,220 | 8,280 | ||
| 2024-11-26 | Byrd Richard EVP & President Interventional | Grant or award | +2,275 | 10,555 | ||
| 2024-11-26 | Byrd Richard EVP & President Interventional | Shares withheld for taxes | −1,204 | 9,351 | ||
| 2024-11-26 | Byrd Richard EVP & President Interventional | Grant or award · Stock Appreciation Rights | +8,699 | 8,699 | ||
| 2024-11-26 | DelOrefice Christopher EVP & Chief Financial Officer | Grant or award | +4,884 | 17,676 | ||
| 2024-11-26 | DelOrefice Christopher EVP & Chief Financial Officer | Grant or award | +9,015 | 26,691 | ||
| 2024-11-26 | DelOrefice Christopher EVP & Chief Financial Officer | Shares withheld for taxes | −5,192 | 21,499 | ||
| 2024-11-26 | DelOrefice Christopher EVP & Chief Financial Officer | Grant or award · Stock Appreciation Rights | +19,138 | 19,138 | ||
| 2024-11-26 | Ezell Antoine C EVP, President Americas & CMO | Grant or award | +1,388 | 10,708 | ||
| 2024-11-26 | Ezell Antoine C EVP, President Americas & CMO | Grant or award | +2,619 | 13,327 |
Page 9 of 28 · 548 trades